For more information about the sale of GLP-1 medications, see our FAQ
There is no middle ground that recovers the medication after either exposure
Gastrointestinal symptoms predominated, including nausea (36.9%), fatigue (16.7% ), vomiting (16.3%), constipation (15.3%), and diarrhea (12.6%)
1 mg cohort 73.5 kg / BMI 26.1
Who Is a Good Candidate for Semaglutide and Who Should Avoid It Semaglutide is appropriate for adults with a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related health condition such as type 2 diabetes, high blood pressure, or sleep apnea
The product is not intended to diagnose, treat, cure, or prevent any disease and should only be handled by qualified professionals operating within controlled scientific environments